Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.
Subscribe to:
Post Comments (Atom)
< + > Transforming Healthcare Operations with Innovation and AI with Dell Technologies and AMD
In case you missed, it, we started a really great conversation about AI in healthcare with AMD and Dell Technologies at the HIMSS annual co...
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
The following is a guest article by Ladd Wiley, Senior Vice President for Global Corporate Affairs, Public Policy, and Advocacy at Epic , ...
-
Robert Connely of Pega says patching legacy systems will give way to true health IT modernization, a security breakthrough will lead artific...
No comments:
Post a Comment